Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10696654 Therapeutic compounds
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 3 Jul, 2024
"update inverses"
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12024509 Therapeutic compounds as inhibitors of the orexin-1 receptor
0
Edits on 13 Sep, 2023
"update inverses"
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11753398 Therapeutic compounds
Edits on 21 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 21 Jul, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10696654
0
Edits on 22 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 22 Apr, 2023
Infobox
Patent Citations Received
US Patent 10828302 Methods of treating depression using orexin-2 receptor antagonists
0
Edits on 31 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 31 Mar, 2023
Infobox
Patent Citations
US Patent 10011595 Ethyldiamine orexin receptor antagonists
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations Received
US Patent 11241432 Methods of treating depression using orexin-2 receptor antagonists
0
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10696654
0
Date of Patent
June 30, 2020
0
Patent Application Number
16073429
0
Date Filed
January 30, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10696654
0
Patent Citations
US Patent 10011595 Ethyldiamine orexin receptor antagonists
0
Patent Citations Received
US Patent 10828302 Methods of treating depression using orexin-2 receptor antagonists
0
US Patent 11241432 Methods of treating depression using orexin-2 receptor antagonists
0
Patent Primary Examiner
Erich A Leeser
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10696654
Edits on 9 Feb, 2022
"update inverses"
Golden AI
edited on 9 Feb, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 11241432 Methods of treating depression using orexin-2 receptor antagonists
Edits on 7 Feb, 2022
"update inverses"
Golden AI
edited on 7 Feb, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 10828302 Methods of treating depression using orexin-2 receptor antagonists
Edits on 5 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 5 Feb, 2022
Edits made to:
Infobox
(
+8
properties)
US Patent 10696654 Therapeutic compounds
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10696654
Date of patent
June 30, 2020
Patent application number
16073429
Date Filed
January 30, 2017
Patent citations
US Patent 10011595 Ethyldiamine orexin receptor antagonists
Patent primary examiner
Erich A Leeser
Find more entities like US Patent 10696654 Therapeutic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE